ATONRA PARTNERS – Neurocrine Biosciences, Inc. Transaction History
ATONRA PARTNERS portfolio value:
$1.18M
portfolio value
ATONRA PARTNERS quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.23% | -255 shares | 73K | $106.21 | 11.18K |
| Q2 2022 | share | Decrease | -15.81% | -2.14K shares | -159K | $97.48 | 11.44K |
| Q1 2022 | share | Increase | +5.27% | 680 shares | 175K | $93.75 | 13.58K |
| Q4 2021 | share | Increase | +9.23% | 1.09K shares | -34K | $84.63 | 12.90K |
| Q3 2021 | share | Increase | +8.39% | 915 shares | 72K | $95.91 | 11.81K |
| Q2 2021 | share | Decrease | -61.63% | -17.51K shares | -1.70M | $97.32 | 10.90K |
| Q1 2021 | share | Increase | +11.74% | 2.98K shares | 326K | $97.25 | 28.41K |
| Q4 2020 | share | Increase | 0.00% | 25.42K shares | 2.43M | $95.85 | 25.42K |